CELZ
Creative Medical Technology Holdings Inc
NASDAQ: CELZ · HEALTHCARE · BIOTECHNOLOGY
$2.25
+1.35% today
Updated 2026-04-30
Market cap
$8.50M
P/E ratio
—
P/S ratio
1,417.06x
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$2 – $6
Volume
0.1M
Creative Medical Technology Holdings Inc (CELZ) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $4800.00 | $124400.00 | $165500.00 | $164500.00 | $87754.00 | $88600.00 | $9000.00 | $11000.00 | $6000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | +2491.7% | +33.0% | -0.6% | -46.7% | +1.0% | -89.8% | +22.2% | -45.5% |
| Cost of revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $766072.00 | $8000.00 | $70375.00 | $45499.00 | $50596.00 | $47949.00 | $28491.00 | $3600.00 | $4400.00 | $125521.00 |
| Gross profit | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $-766072.00 | $-3200.00 | $54025.00 | $120001.00 | $113904.00 | $39805.00 | $60109.00 | $5400.00 | $6600.00 | $-119521.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | -66.7% | 43.4% | 72.5% | 69.2% | 45.4% | 67.8% | 60.0% | 60.0% | -1992.0% |
| R&D | — | — | — | — | — | — | — | — | $85334.00 | $85334.00 | $85334.00 | $260085.00 | $96621.00 | $0.00 | $0.00 | $109180.00 | $6.27M | $1.97M | $2.40M | $2.26M |
| SG&A | $1431.00 | $13617.00 | $53490.00 | $30553.00 | $14290.00 | — | $20096.00 | $20120.00 | $19426.00 | $20831.00 | $664984.00 | $898526.00 | $1.05M | $1.22M | $1.16M | $2.96M | $3.94M | $3.06M | $3.24M | $3.76M |
| Operating income | $-1431.00 | $-13617.00 | $-53490.00 | $-30553.00 | $-14290.00 | $-19830.00 | $-20096.00 | $-20120.00 | $-19426.00 | $-20831.00 | $-766072.00 | $-1.18M | $-1.11M | $-1.13M | $-1.11M | $-3.13M | $-10.24M | $-5.62M | $-5.74M | $-6.14M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | -24537.6% | -895.7% | -682.9% | -677.7% | -3562.2% | -11562.5% | -62445.9% | -52216.9% | -102380.2% |
| EBITDA | $-1431.00 | $-13617.00 | $-53490.00 | $-30553.00 | $-14290.00 | $-19830.00 | $-20096.00 | $-20120.00 | $-19426.00 | $-20831.00 | $-750318.00 | $-1.16M | $-1.09M | $-6.56M | $-35.03M | $23.58M | $-10.15M | $-5.53M | $-5.63M | $-6.02M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | -24204.4% | -878.7% | -3964.5% | -21294.1% | 26873.2% | -11458.6% | -61395.0% | -51212.8% | -100324.8% |
| EBIT | $-1431.00 | $-13617.00 | $-53490.00 | $-30553.00 | $-14290.00 | $-19830.00 | $-20096.00 | $-20120.00 | $-19426.00 | $-20831.00 | $-759674.00 | $-1.18M | $-1.11M | $-6.59M | $-35.10M | $23.49M | $-10.24M | $-5.62M | $-5.74M | $-6.14M |
| Interest expense | — | — | — | $1057.00 | $2966.00 | $4225.00 | $5489.00 | $7162.00 | $8586.00 | $9930.00 | $6398.00 | $377587.00 | $1.36M | $1.90M | $1.23M | $4.28M | $100328.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1372.00 | $-9544.00 | $-52636.00 | $-31610.00 | $-17256.00 | $-24055.00 | $-25585.00 | $-27282.00 | $-28012.00 | $-30761.00 | $-766072.00 | $-2.66M | $-13.66M | $-8.48M | $-36.33M | $19.21M | $-10.14M | $-5.29M | $-5.49M | $-6.00M |
| Net income growth (YoY) | — | -795.6% | -451.5% | +39.9% | +45.4% | -39.4% | -6.4% | -6.6% | -2.7% | -9.8% | -2390.4% | -247.1% | -413.5% | +37.9% | -328.2% | +152.9% | -152.8% | +47.9% | -3.9% | -9.1% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | -55398.1% | -10977.2% | -5126.1% | -22082.2% | 21892.8% | -11449.3% | -58739.7% | -49940.7% | -99916.8% |